Skip to main content

Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia

Publication ,  Journal Article
Farnier, M; Chen, E; Johnson-Levonas, AO; McCrary Sisk, C; Mitchel, YB
Published in: Vascular Health and Risk Management
May 2014

Duke Scholars

Published In

Vascular Health and Risk Management

DOI

EISSN

1178-2048

Publication Date

May 2014

Start / End Page

279 / 279

Publisher

Informa UK Limited

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Farnier, M., Chen, E., Johnson-Levonas, A. O., McCrary Sisk, C., & Mitchel, Y. B. (2014). Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia. Vascular Health and Risk Management, 279–279. https://doi.org/10.2147/vhrm.s58694
Farnier, Michel, Erluo Chen, Amy O. Johnson-Levonas, Christine McCrary Sisk, and Yale B. Mitchel. “Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.” Vascular Health and Risk Management, May 2014, 279–279. https://doi.org/10.2147/vhrm.s58694.
Farnier, Michel, et al. “Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.” Vascular Health and Risk Management, Informa UK Limited, May 2014, pp. 279–279. Crossref, doi:10.2147/vhrm.s58694.
Farnier M, Chen E, Johnson-Levonas AO, McCrary Sisk C, Mitchel YB. Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia. Vascular Health and Risk Management. Informa UK Limited; 2014 May;279–279.

Published In

Vascular Health and Risk Management

DOI

EISSN

1178-2048

Publication Date

May 2014

Start / End Page

279 / 279

Publisher

Informa UK Limited

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences